Mutual of America Capital Management LLC Sells 873 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Mutual of America Capital Management LLC lowered its position in Axon Enterprise, Inc. (NASDAQ:AXONFree Report) by 6.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 13,513 shares of the biotechnology company’s stock after selling 873 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Axon Enterprise were worth $3,491,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Westfield Capital Management Co. LP lifted its position in shares of Axon Enterprise by 184.3% in the 3rd quarter. Westfield Capital Management Co. LP now owns 696,193 shares of the biotechnology company’s stock worth $138,535,000 after acquiring an additional 451,350 shares during the period. Vaughan Nelson Investment Management L.P. lifted its position in shares of Axon Enterprise by 18.4% in the 4th quarter. Vaughan Nelson Investment Management L.P. now owns 104,587 shares of the biotechnology company’s stock worth $27,019,000 after acquiring an additional 16,230 shares during the period. BKM Wealth Management LLC bought a new stake in shares of Axon Enterprise in the 4th quarter worth approximately $32,000. Sumitomo Mitsui Trust Holdings Inc. lifted its position in shares of Axon Enterprise by 0.3% in the 3rd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 147,345 shares of the biotechnology company’s stock worth $29,320,000 after acquiring an additional 495 shares during the period. Finally, International Assets Investment Management LLC bought a new stake in shares of Axon Enterprise in the 4th quarter worth approximately $39,907,000. Institutional investors own 79.08% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on AXON. JPMorgan Chase & Co. increased their target price on Axon Enterprise from $330.00 to $365.00 and gave the stock an “overweight” rating in a report on Thursday, April 11th. StockNews.com cut Axon Enterprise from a “buy” rating to a “hold” rating in a report on Thursday, March 14th. JMP Securities increased their target price on Axon Enterprise from $250.00 to $285.00 and gave the stock a “market outperform” rating in a report on Tuesday, February 6th. The Goldman Sachs Group increased their target price on Axon Enterprise from $297.00 to $339.00 and gave the stock a “buy” rating in a report on Wednesday, February 28th. Finally, Needham & Company LLC increased their target price on Axon Enterprise from $315.00 to $400.00 and gave the stock a “buy” rating in a report on Wednesday, April 10th. Two analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to data from MarketBeat, Axon Enterprise has a consensus rating of “Moderate Buy” and a consensus target price of $312.64.

View Our Latest Research Report on Axon Enterprise

Axon Enterprise Trading Down 0.2 %

AXON stock opened at $299.82 on Thursday. The business has a fifty day moving average price of $299.84 and a 200 day moving average price of $257.02. Axon Enterprise, Inc. has a fifty-two week low of $175.37 and a fifty-two week high of $329.87. The stock has a market capitalization of $22.62 billion, a price-to-earnings ratio of 130.36 and a beta of 0.93. The company has a debt-to-equity ratio of 0.42, a current ratio of 3.00 and a quick ratio of 2.66.

Axon Enterprise (NASDAQ:AXONGet Free Report) last released its quarterly earnings results on Tuesday, February 27th. The biotechnology company reported $0.77 earnings per share for the quarter, beating analysts’ consensus estimates of $0.48 by $0.29. Axon Enterprise had a return on equity of 14.11% and a net margin of 11.14%. The firm had revenue of $432.14 million during the quarter, compared to analysts’ expectations of $418.97 million. Analysts expect that Axon Enterprise, Inc. will post 2.43 EPS for the current fiscal year.

Axon Enterprise Profile

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

See Also

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXONFree Report).

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.